The significant equity raise creates near-term dilution overhang. Monitor for potential further capital needs or updates on biosimilar pipeline progress. The stock may face pressure as the offering closes and shares enter the market.
Price Chart
Executive Summary
Alvotech priced a dilutive public offering of 22.7M shares at $3.75/share, raising ~$85M in gross proceeds, with an additional concurrent private placement of 17.8M shares raising ~$67M. Total gross proceeds of ~$152M (~$165M if underwriters exercise full option) will fund biosimilar development and working capital, representing ~12% dilution relative to market cap.
Key Financial Metrics
Key Facts
- Priced public offering of 22,666,667 ordinary shares at $3.75 per share
- Concurrent private placement of 17,826,666 ordinary shares at same price
- Total gross proceeds expected ~$152M (or ~$165M with full underwriter option)
- Proceeds to fund biosimilar development, working capital, and general corporate purposes
- Offering expected to close June 17, 2026; private placement expected June 25, 2026
Financial Impact
~$152M gross proceeds from combined offerings, representing approximately 11.7% dilution based on $1.3B market cap
Risk Factors
- Dilution of ~12% from combined offerings
- Potential overhang from additional 3.4M share underwriter option
- Use of proceeds for development may not yield near-term revenue
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3312252 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 7d ago | 6-K | $5.12 | awaiting T+20 | — | $4.70 (−8.11%) |
Oct 14, 2026 13d ago | 6-K | $5.17 | awaiting T+20 | — | $4.70 (−8.99%) |
Oct 7, 2026 20d ago | 6-K | $5.85 | awaiting T+20 | — | $4.70 (−19.57%) |
Oct 5, 2026 22d ago | 6-K | $6.11 | awaiting T+20 | — | $4.70 (−23.00%) |
Oct 5, 2026 22d ago | Press Release | $6.11 | awaiting T+20 | — | $4.70 (−23.00%) |
Aug 31, 2026 8w ago | 6-K | $5.19 $5.92 | ▲ +14.07% | ▲ +14.44% | $4.70 (−9.34%) |
Aug 21, 2026 9w ago | 6-K | $4.43 $5.88 | ▲ +32.73% | ▲ +31.72% | $4.70 (+6.21%) |
Aug 19, 2026 9w ago | Press Release | $4.27 $5.87 | ▼ −37.47% | ▼ −37.59% | $4.70 (−10.19%) |
Jul 29, 2026 12w ago | 6-K | $3.53 $4.91 | ▲ +39.09% | ▲ +34.07% | $4.70 (+33.29%) |
Jul 3, 2026 16w ago | Press Release | $3.46 $4.12 | ▲ +19.08% | ▲ +19.64% | $4.70 (+35.98%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers